Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Long-term epidemiologic longitudinal study on the effect of vaccines on public inoculation.

Matsuoka I, Matsuoka T, Matsuoka A, Shigemura T, Agematsu K, Koike K.

Turk J Pediatr. 2012 Jul-Aug;54(4):376-81.

PMID:
23692718
[PubMed - indexed for MEDLINE]
Free Article
2.

Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.

Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K.

Am J Infect Control. 2003 May;31(3):157-62.

PMID:
12734521
[PubMed - indexed for MEDLINE]
3.

[Overview of measles, mumps, rubella and varicella vaccination in adolescents and adults].

Quast U, Arndt U.

Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S77-81. doi: 10.1055/s-0029-1220214. Epub 2009 Apr 7. Review. German.

PMID:
19353476
[PubMed - indexed for MEDLINE]
4.

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.

Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.

N Engl J Med. 1994 Nov 24;331(21):1397-402.

PMID:
7969278
[PubMed - indexed for MEDLINE]
Free Article
5.

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, Giovannoni G, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group.

Neuroepidemiology. 2009;32(4):257-62. doi: 10.1159/000201564. Epub 2009 Feb 11.

PMID:
19209005
[PubMed - indexed for MEDLINE]
6.

A new combination vaccine for measles, mumps, rubella and varicella.

Zareba G.

Drugs Today (Barc). 2006 May;42(5):321-9. Review.

PMID:
16801995
[PubMed - indexed for MEDLINE]
7.

Combination measles, mumps, rubella and varicella vaccine.

Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA.

Pediatrics. 1986 Oct;78(4 Pt 2):742-7.

PMID:
3763291
[PubMed - indexed for MEDLINE]
8.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

PMID:
20448530
[PubMed - indexed for MEDLINE]
Free Article
9.

Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.

Heath TC, Burgess MA, O'Brien ED.

Commun Dis Intell. 1998 Aug 6;22(8):159. No abstract available.

PMID:
9735551
[PubMed - indexed for MEDLINE]
10.

A combination vaccine against measles, mumps, rubella and varicella.

Knuf M, Faber J, Barth I, Habermehl P.

Drugs Today (Barc). 2008 Apr;44(4):279-92. Review.

PMID:
18536786
[PubMed - indexed for MEDLINE]
11.

Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.

Shinefield HR, Black S, Kuter BJ.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S152-5. doi: 10.1086/522126.

PMID:
18419390
[PubMed - indexed for MEDLINE]
Free Article
12.

Pediatric sentinel surveillance of vaccine-preventable diseases in Italy.

Ciofi Degli Atti ML, Salmaso S, Bella A, Arigliani R, Gangemi M, Chiamenti G, Brusoni G, Tozzi AE; Pediatric Sentinel Surveillance Study Group.

Pediatr Infect Dis J. 2002 Aug;21(8):763-8.

PMID:
12192166
[PubMed - indexed for MEDLINE]
13.

[Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].

Salvadori P.

Ann Ig. 1998 Jan-Feb;10(1):19-24. Italian. No abstract available.

PMID:
9616974
[PubMed - indexed for MEDLINE]
14.

Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland.

Peltola H, Karanko V, Kurki T, Hukkanen V, Virtanen M, Penttinen K, Nissinen M, Heinonen OP.

Lancet. 1986 Jan 18;1(8473):137-9.

PMID:
2867355
[PubMed - indexed for MEDLINE]
15.

The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France.

Coudeville L, Paree F, Lebrun T, Sailly J.

Vaccine. 1999 Jan;17(2):142-51.

PMID:
9987148
[PubMed - indexed for MEDLINE]
16.

[Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].

Janaszek-Seydlitz W, Bucholc B, Wysokińska T, Górska P, Gniadek G.

Przegl Epidemiol. 2003;57(2):281-8. Polish.

PMID:
12910596
[PubMed - indexed for MEDLINE]
17.

Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.

Smorodintsev AA, Nasibov MN, Jakovleva NV.

Bull World Health Organ. 1970;42(2):283-9.

PMID:
5310140
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Sentinel surveillance shows small decline in MMR coverage.

[No authors listed]

Commun Dis Rep CDR Wkly. 1998 Sep 4;8(36):317, 320. No abstract available.

PMID:
9782644
[PubMed - indexed for MEDLINE]
19.

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ; Consistency Lot Study Group for ProQuad.

Pediatr Infect Dis J. 2006 Jul;25(7):615-22.

PMID:
16804432
[PubMed - indexed for MEDLINE]
20.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk